Anavex Life Sciences
AVXL
#7719
Rank
โ‚น32.52 B
Marketcap
โ‚น363.99
Share price
-2.19%
Change (1 day)
-49.26%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): -โ‚น48.51

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is -โ‚น51.61. In 2024 the company made an earnings per share (EPS) of -โ‚น47.08 an increase over its 2023 EPS that were of -โ‚น54.33.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น48.513.02%
2024-โ‚น47.08-13.33%
2023-โ‚น54.33-3.23%
2022-โ‚น56.1414.81%
2021-โ‚น48.8920%
2020-โ‚น40.74-16.67%
2019-โ‚น48.8938.46%
2018-โ‚น35.3118.18%
2017-โ‚น29.88-21.43%
2016-โ‚น38.03-35.38%
2015-โ‚น58.85-36.27%
2014-โ‚น92.35112.5%
2013-โ‚น43.46-58.62%
2012-โ‚น105.03-0%
2011-โ‚น105.03-29.27%
2010-โ‚น148.4951.85%
2009-โ‚น97.79-0%
2008-โ‚น97.79237.5%
2007-โ‚น28.97
2006N/A-100%
2005-โ‚น3.62499.97%
2004-โ‚น0.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น216.40-519.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น4.53-91.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น90.54-275.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น5,523 10,601.75%๐Ÿ‡บ๐Ÿ‡ธ USA